FNG-23702-79690
5 vaccinations
6 coded responses
40 check-ins
6 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 36-40
- ZIP prefix
- 021 / MA
- Registered
- 2020-12-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-26
Registered in v-safe
-
2020-12-26
Dose 1 — Moderna
- 2020-12-26
- 2020-12-27
-
2020-12-28
Survey response — days 1–6 daily, dose 1MedDRA: Injection site rash, Injection site reaction, Skin lesion — Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: Pink nonerythematous nonpruritic patch lesion at injection site/right deltoidMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-28
-
2020-12-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2020-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2021-01-01
- 2021-01-02
- 2021-01-09
-
2021-01-20
Dose 2 — Moderna
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body achesAdult check-in
- 2021-01-23
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-20
- 2021-02-24
- 2021-03-03
- 2021-04-21
- 2021-07-21
-
2021-10-22
Dose 3 — Moderna
-
2021-10-24
Survey response — days 1–6 daily, dose 3MedDRA: Headache, Self-medication — Feeling: Good · Site: PainFree text: Mild headache yesterday, cleared with acetaminophenMedDRA releases: 2024-11 · check-in free text available
- 2021-10-25
- 2021-10-26
- 2021-10-27
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-11-21
-
2021-11-30
Survey response — day 35, dose 3MedDRA: Nasal congestion, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Moderate nasal congestion and runny nose. No fever or chills. No body aches. No cough, no sneezing. Recent travel from Ireland (11/24-11/29) so I started working remotely as a precaution.MedDRA releases: 2024-11 · check-in free text available
-
2021-12-03
Survey response — day 42, dose 3MedDRA: Nasal congestion — Feeling: GoodFree text: Nasal congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-01-21
-
2022-03-22
Dose 4 — Pfizer-BioNTech
- 2022-04-22
-
2022-09-16
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-08
Survey response — day 21, dose 5MedDRA: Cold sweat, Cough, Exposure to SARS-CoV-2, Respiratory symptom, Rhinorrhoea, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: URI symptoms of runny nose, dry cough, cold sweats (but no fever) starting 10/1/22. Tested positive via home rapid Covid Test 10/3/22. Likely Covid exposure on 9/30/22 (trip guest with cough)MedDRA releases: 2024-11 · check-in free text available
- 2022-10-14
- 2022-10-21
- 2022-10-28
-
2022-12-16
Survey response — 3 months, dose 5MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: COVID infection one week after bivalent vaccination. Mild symptoms only.MedDRA releases: 2024-11 · check-in free text available
- 2023-03-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-26 | Moderna | |
| 2 | 2021-01-20 | Moderna | |
| 3 | 2021-10-22 | Moderna | No |
| 4 | 2022-03-22 | Pfizer-BioNTech | No |
| 5 | 2022-09-16 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Pink nonerythematous nonpruritic patch lesion at injection site/right deltoid
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Mild headache yesterday, cleared with acetaminophen
Release 10 — day 35, dose 3
Symptoms: Moderate nasal congestion and runny nose. No fever or chills. No body aches. No cough, no sneezing. Recent travel from Ireland (11/24-11/29) so I started working remotely as a precaution.
Release 10 — day 42, dose 3
Symptoms: Nasal congestion
Release 12 — day 21, dose 5
Symptoms: URI symptoms of runny nose, dry cough, cold sweats (but no fever) starting 10/1/22. Tested positive via home rapid Covid Test 10/3/22. Likely Covid exposure on 9/30/22 (trip guest with cough)
Release 12 — 3 months, dose 5
Symptoms: COVID infection one week after bivalent vaccination. Mild symptoms only.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cold sweat | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Respiratory symptom | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Injection site rash | ✓ | ✓ | ✓ |
| SRO | Injection site reaction | ✓ | ✓ | ✓ |
| SRO | Self-medication | · | · | ✓ |
| SRO | Skin lesion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release